Research programme - growth factor therapeutics - Branching Tree

Drug Profile

Research programme - growth factor therapeutics - Branching Tree

Alternative Names: Spinal Bliss; Spinal Bliss - Branching Tree

Latest Information Update: 10 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Branching Tree
  • Class Growth factors
  • Mechanism of Action Growth factor receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Spinal cord disorders

Most Recent Events

  • 02 Nov 2016 Research programme - growth factor therapeutics - Branching Tree is available for licensing as of 02 Nov 2016. http://www.branchingtree.com/Blog/Blog.html (Branching Tree website, November 2016)
  • 02 Nov 2016 Branching Tree files for patent protection with for growth factor before November 2016 (Branching Tree website, November 2016)
  • 02 Nov 2016 Preclinical trials in Spinal cord disorders in Netherlands before November 2016 (Branching Tree website, November 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top